Recent Updates
Recently added Catalysts
WAT Positive Sentiment

Waters Corporation Schedules Second Quarter 2026 Earnings Conference Call

Key Takeaway: Waters Corporation has announced its Q2 2026 earnings conference call scheduled for August 4, 2026. The call will take place at 8:00 a.m. Eastern Time, with a live webcast available on the company's Investor Relations website. A replay of the call will be accessible until September 1, 2026.
Price reaction · baseline $378.13 (2026-07-01 close) · hit pre-market · clean, no other WAT news in the window
day 0 close · peak
+0.3%

Market Sentiment Analysis

POSITIVE FACTORS

  • Waters Corporation is a leader in life sciences and diagnostics.
  • The company focuses on innovative analytical technologies.
  • They aim to improve patient outcomes and ensure safety in food and water.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~19 mo
Low dilution risk
Lead asset
CYTALUX preoperatively
Phase 2 · Esophageal Cancer

Full Press Release Details

MILFORD, Mass.,July 2, 2026/PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q2 2026 financial results conference call on Tuesday, August 4, 2026, at 8:00 a.m. Eastern Time. A live webcast of the presentation will be available on Waters' Investor Relations website athttps://ir.waters.com. A replay of the webcast will also be available until at least September 1, 2026, at midnight Eastern Time.
About Waters Corporation
Waters Corporation (NYSE:WAT) is a global leader in life sciences and diagnostics, dedicated to accelerating the benefits of pioneering science through analytical technologies, informatics, and service. With a focus on regulated, high-volume testing environments, our innovative portfolio harnesses deep scientific expertise across chemistry, physics, and biology. We collaborate with customers around the world to advance the release of effective, high-quality medicines, ensure the safety of food and water, and drive better patient outcomes by detecting diseases earlier, managing routine infections, and combating antibiotic resistance. Through a shared culture of relentless innovation, our passionate team of ~16,000 colleagues turn scientific challenges into breakthroughs that improve lives worldwide. For more information, please visitwww.waters.com/about.
Caspar Tudor, Head of Investor Relations[email protected]

Frequently Asked Questions

When is Waters Corporation's Q2 2026 earnings call?

The Q2 2026 earnings call is scheduled for August 4, 2026, at 8:00 a.m. ET.

How can I access the earnings call webcast?

The live webcast will be available on Waters' Investor Relations website.

Will there be a replay of the earnings call?

Yes, a replay will be available until at least September 1, 2026.

What is the focus of Waters Corporation?

Waters Corporation focuses on life sciences, diagnostics, and analytical technologies.

Last updated: Jul 2, 2026